Monopar Therapeutics Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Monopar Therapeutics Inc. stock issued during period, value, other for the quarter ending 2021-09-30 was -$9.98K.
- Monopar Therapeutics Inc. stock issued during period, value, other for the quarter ending 2021-06-30 was -$24.00K, a 102.52% decline year-over-year.
- Monopar Therapeutics Inc. stock issued during period, value, other for the quarter ending 2021-03-31 was -$21.50K.
- Monopar Therapeutics Inc. stock issued during period, value, other for the quarter ending 2020-06-30 was $950.69K.
- Monopar Therapeutics Inc. stock issued during period, value, other for fiscal 2022 was -$76.63K.
- Monopar Therapeutics Inc. stock issued during period, value, other for fiscal 2021 was -$63.25K, a 100.77% decline from fiscal 2020.
- Monopar Therapeutics Inc. stock issued during period, value, other for fiscal 2020 was $8.18M.
- Monopar Therapeutics Inc. stock issued during period, value, other for fiscal 2016 was $1.26M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2022-12-31 | -$76.63K 10-K · filed 2023-03-23 | |
| 2021-12-31 | -$63.25K 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$9.98K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$24.00K 10-Q · filed 2021-11-12 | |
| 2021-03-31 | -$21.50K 10-Q · filed 2021-11-12 | |
| 2020-12-31 | $8.18M 10-K · filed 2021-03-25 | |
| 2020-06-30 | $950.69K 10-Q · filed 2020-08-06 | |
| 2016-12-31 | $1.26M 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |